The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 17,934 | 370,000 | SH | OTR | 370,000 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 5,088 | 550,000 | SH | OTR | 550,000 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 10,379 | 416,495 | SH | OTR | 416,495 | 0 | 0 | ||
AGENUS INC | COM NEW | 00847G705 | 15,720 | 4,000,000 | SH | OTR | 4,000,000 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 48,506 | 675,000 | SH | OTR | 675,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 48,440 | 7,000,000 | SH | OTR | 7,000,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 35,061 | 2,325,000 | SH | OTR | 2,325,000 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 29,042 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 51,580 | 2,084,883 | SH | OTR | 2,084,883 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 38,498 | 170,926 | SH | OTR | 170,926 | 0 | 0 | ||
ARTARA THERAPEUTICS INC | COM | 04300J107 | 6,135 | 209,227 | SH | OTR | 209,227 | 0 | 0 | ||
ATRECA INC | CL A COM | 04965G109 | 36,891 | 1,733,583 | SH | OTR | 1,733,583 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 31,689 | 1,121,327 | SH | OTR | 1,121,327 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 174,270 | 925,000 | SH | OTR | 925,000 | 0 | 0 | ||
BELLEROPHON THERAPEUTICS INC | COM NEW | 078771300 | 1,240 | 98,809 | SH | OTR | 98,809 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 18,265 | 1,775,000 | SH | OTR | 1,775,000 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 30,835 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 84,946 | 2,014,858 | SH | OTR | 2,014,858 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | 17,434 | 1,566,361 | SH | OTR | 1,566,361 | 0 | 0 | ||
CELLECTAR BIOSCIENCES INC | COM PAR | 15117F500 | 1,178 | 920,000 | SH | OTR | 920,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 13,000 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
COMPUGEN LTD | ORD | M25722105 | 35,803 | 2,383,673 | SH | OTR | 2,383,673 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 6,980 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 30,882 | 7,034,598 | SH | OTR | 7,034,598 | 0 | 0 | ||
DIREXION SHS ETF TR | DAILY S&P BIOTEC | 25460E539 | 24,290 | 7,000,000 | SH | OTR | 7,000,000 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 50,027 | 975,000 | SH | OTR | 975,000 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 12,911 | 705,882 | SH | OTR | 705,882 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 15,783 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 33,311 | 2,562,358 | SH | OTR | 2,562,358 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 31,302 | 2,202,812 | SH | OTR | 2,202,812 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 234,117 | 6,606,000 | SH | OTR | 6,606,000 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 6,037 | 126,000 | SH | OTR | 126,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 5,490 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 31,774 | 6,205,882 | SH | OTR | 6,205,882 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 7,404 | 290,577 | SH | OTR | 290,577 | 0 | 0 | ||
KODIAK SCIENCES INC | COM | 50015M109 | 9,803 | 181,138 | SH | OTR | 181,138 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 13,770 | 844,789 | SH | OTR | 844,789 | 0 | 0 | ||
LA JOLLA PHARMACEUTICAL CO | COM PAR $.0001 2 | 503459604 | 3,794 | 890,700 | SH | OTR | 890,700 | 0 | 0 | ||
LIFESCI ACQUISITION CORP | UNIT 03/31/2025 | 53228P208 | 2,988 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM | 56854Q101 | 24,384 | 9,600,000 | SH | OTR | 9,600,000 | 0 | 0 | ||
MATINAS BIOPHARMA HLDGS INC | COM | 576810105 | 8,873 | 11,478,634 | SH | OTR | 11,478,634 | 0 | 0 | ||
MEI PHARMA INC | COM NEW | 55279B202 | 12,031 | 2,913,091 | SH | OTR | 2,913,091 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 12,331 | 4,029,649 | SH | OTR | 4,029,649 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 4,166 | 1,102,194 | SH | OTR | 1,102,194 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 201,574 | 1,765,560 | SH | OTR | 1,765,560 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 6,169 | 317,000 | SH | OTR | 317,000 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 16,754 | 1,009,255 | SH | OTR | 1,009,255 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 142,405 | 3,363,377 | SH | OTR | 3,363,377 | 0 | 0 | ||
PASSAGE BIO INC | COM | 702712100 | 52,701 | 1,928,315 | SH | OTR | 1,928,315 | 0 | 0 | ||
PREVAIL THERAPEUTICS INC | COM | 74140Y101 | 16,734 | 1,123,105 | SH | OTR | 1,123,105 | 0 | 0 | ||
PRINCIPIA BIOPHARMA INC | COM | 74257L108 | 36,293 | 607,000 | SH | OTR | 607,000 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 13,425 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 93,424 | 2,959,264 | SH | OTR | 2,959,264 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 30,684 | 1,466,051 | SH | OTR | 1,466,051 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 45,489 | 1,094,000 | SH | OTR | 1,094,000 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 67,968 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
SELECTA BIOSCIENCES INC | COM | 816212104 | 9,327 | 3,284,072 | SH | OTR | 3,284,072 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 4,488 | 1,531,872 | SH | OTR | 1,531,872 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 87,188 | 2,075,905 | SH | OTR | 2,075,905 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 33,905 | 2,287,782 | SH | OTR | 2,287,782 | 0 | 0 | ||
TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 32,967 | 4,075,000 | SH | OTR | 4,075,000 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 34,489 | 765,400 | SH | OTR | 765,400 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 7,524 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 737 | 27,300 | SH | OTR | 27,300 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 5,952 | 165,000 | SH | OTR | 165,000 | 0 | 0 |